Navigation Links
Nanofibrillar cellulose film to ease performing medical tests
Date:10/25/2012

Researchers at Aalto University in Finland have succeeded in developing a durable and affordable nanofibrillar cellulose film platform to support medical testing. New environmentally friendly, reliable nanofibrillar cellulose (NFC) platforms are more diverse than plastic films. New film can be made, for instance, hydrophobic, hydrophilic and the electric charge can be changed. This will enhance the possibility of conducting thousands of different medical tests at home or in physicians' receptions instead of waiting for results from laboratories.

A platform is coated with the new film in the factory. The film is injected with substances that will react to the tested substance. At the place of testing, blood, water or another test material will be applied on to the film. The antibody injected onto the film will absorb the sample, depending on whether it contains substances causing allergic reactions, or bacteria, for example. Then the test result is visualised with the help of colour changing chemistry, for example.

Thanks to the new film, various tests can be conducted faster without compromising reliability. It will now be easier to detect microbes that cause illnesses in the physician's reception, or to monitor allergens at home. In addition to medical diagnostics, the film can be utilised to study water purity, for example, says doctoral candidate Hannes Orelma at Aalto University.

Previous attempts to produce a nanofibrillar cellulose platform have failed when the porous plate absorbed part of the sample. Now researchers have developed a method of producing a water proof nanofibrillar cellulose gel that will not absorb samples. They have also made great efforts to ensure sufficient film durability.


'/>"/>
Contact: Hannes Orelma
hannes.orelma@aalto.fi
358-503-441-074
Aalto University
Source:Eurekalert  

Page: 1

Related biology technology :

1. Air Products to Feature Medical and Industrial Grade Gas Solutions for Pharma, Biotech, and Life Science Applications at Mid-Atlantic Bio Conference
2. Germany Prioritizes Medical Biotechnology with New Initiatives
3. University of Kentucky Medical Center Transplants States 1st SynCardia Total Artificial Heart Patient
4. Medical Diagnostic Laboratories, L.L.C. Announces a Complimentary Reflex Test to Determine Azithromycin Resistance in Chlamydia Trachomatis
5. Medical Marijuana, Inc. Portfolio Company PhytoSPHERE Systems Announces Successful Production of Hemp Harvesting for High Value CBD Oil
6. AFCell Medical Reports Results from the Retrospective Study of a Novel Allograft Membrane to Prevent Post-Operative Adhesions in the Repair of Peroneal and Posterior Tibial Tendons
7. Tufts Medical Center Announces Inaugural INNOVATION Day: Innovating a Path to Market
8. Texas Medical Center, the largest concentration of medical research, educational and healthcare organizations in the world, announces the first Houston Stem Cell Summit to highlight the latest stem cell research and commercialization efforts
9. Global Medical Laboratories Industry
10. MarketsandMarkets: Global Refurbished Medical Equipments Market worth $8.45 Billion by 2017
11. Medical Marijuana Inc. Product, CanChew Bio-Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Nanofibrillar cellulose film to ease performing medical tests
(Date:6/23/2016)... , ... June 23, 2016 , ... ... YM (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. ... microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory and ...
(Date:6/23/2016)...   EpiBiome , a precision microbiome engineering company, ... financing from Silicon Valley Bank (SVB). The financing will ... its drug development efforts, as well as purchase additional ... has been an incredible strategic partner to us – ... would provide," said Dr. Aeron Tynes Hammack , ...
(Date:6/23/2016)... NC (PRWEB) , ... June 23, 2016 , ... In ... University Hospital in Denmark detail how a patient who developed lymphedema after being treated ... tissue. The results could change the paradigm for dealing with this debilitating, frequent side ...
(Date:6/23/2016)... LONDON , June 23, 2016 ... & Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... Review , the peer-reviewed journal from touchONCOLOGY, ... the escalating cost of cancer care is placing ... a result of expensive biologic therapies. With the ...
Breaking Biology Technology:
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
(Date:3/29/2016)... March 29, 2016 LegacyXChange, Inc. ... "LEGX" and SelectaDNA/CSI Protect are pleased to announce our ... in a variety of writing instruments, ensuring athletes signatures ... created collectibles from athletes on LegacyXChange will be assured ... the DNA. Bill Bollander , CEO ...
Breaking Biology News(10 mins):